Company: APXIF
Filing Date: 2025-07-03
Form Type: F-4/A
Source: 0001213900-25-061545
Chunk: 426

Company: APx Acquisition Corp. I
Filing Date: 2025-07-03
Form: F-4/A
Chunk 426
---
ow. When the cash is collected by the financial institution, the liability and the receivables are de -recognised. This transaction is reflected in the cash flow statement as an operating cash inflow for the reduction of the accounts receivable, and a financial cash outflow for the cancellation of the financial debt. Net cash generated from / (used in) investing activities Net cash generated from/(used in) investing activities changed by $26,216, from a net cash generated of $25,705 for the six months ended December31, 2023, to a net cash outflow of $511 for the six months ended December31, 2024. This change was primarily attributable to the absence of proceeds from disposals of short -terminvestments during the current period, compared to the $45,303 generated in the same period of 2023. Although capital expenditures decreased significantly, from $19,598 to $511, the lack of investment disposals resulted in a net outflow for the current period. Net cash used in investing activities changed by $529,988, from a net cash outflow of $529,825 for the year ended June 30, 2023, to a net cash inflow of $163 for the year ended June 30, 2024. This change was primarily attributable to the absence of capitalized expenditures on intangible assets, in comparison to the prior year, which included capital investments related to the development of new diagnostic tests for the Heritas Diagnostics segment and the Rewell platform.

220 It is important to note that, while the Company continued its research and development efforts related to the Rewell platform and the advancement of clinical genetic products during the year ended June 30, 2024 and through the six -monthperiod ended December31, 2024, these expenditures were not capitalized. As outlined in the research and development expenses section, the increase in R&D costs was driven by outsourced third -partyservices for platform enhancements, and functional upgrades, as well as increased personnel expenses. However, these activities did not meet the capitalization criteria under IFRS and, in accordance with applicable accounting standards, were recorded as expenses, resulting in no capitalized intangible asset additions during the period. Net cash generated from financing activities Net cash generated from financing activities decreased by $80,023, or 9.3%, from $857,149 for the six months ended December31, 2023, to $777,126 for the six months ended December31,